Denosumab
Amgen,daiichi sankyo
['denosumab', 'breast', 'bcsm']
abcsg-18: adjuvant denosumab q6 mo with ai in postmenopausal women with early breast cancer. no osteonecrosis of the jaw seen. dfs hr 0.83; suggestion of more benefit if start early. bone metastasis free survival hr 0.81. os hr 0.80. #asco22 #bcsm 
Medical oncologist @Intermountain, Director of Breast Oncology. Clinical research, quality improvement, cardio-oncology, provider wellness. All tweets my own.